Intellectual disability and cancer in children: An analysis of the decision-making process

被引:1
作者
Dangles, Marie-Therese [1 ,2 ]
Davous, Dominique [3 ]
Vialle, Guenola [4 ]
Auvrignon, Anne [5 ]
Angellier, Elisabeth [6 ]
Bourdeaut, Franck [7 ]
机构
[1] Hop Necker Enfants Malad, Serv Neurol Pediat, 149 Rue Sevres, F-75015 Paris, France
[2] Univ Paris, Paris, France
[3] Hop St Louis, Grp Reflex & Rech Sein Espace Eth Reg Ile France, F-75010 Paris, France
[4] Mission PALIPED RIFHOP, Reseau Ile France Hematol Oncol & Soins Palliatif, 3-5 Rue Metz, F-75010 Paris, France
[5] Hop Armand Trousseau, Serv Hematol Pediat, 26 Ave Dr Arnold Netter, F-75012 Paris, France
[6] Inst Curie, Dept Interdisciplinaire Soins Support Patient Onc, F-92210 St Cloud, France
[7] Inst Curie, Serv Oncol Pediat, SIREDO, 26 Rue Ulm, F-75005 Paris, France
关键词
Ethics; Decision-making; Children; Pediatrics; Intellectual disability; Cancer; CHILDHOOD; CARE; NEUROTOXICITY; TOXICITY; LEUKEMIA; RISK;
D O I
10.1016/j.bulcan.2021.02.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim > The aim was to describe and to analyze the ethics of decision-making in situations involving children with intellectual disability and cancer, from the referent- doctor's point-ofview, in pediatric oncology units in France. Methods > Pediatricians working in pediatric oncology units were interviewed through an online questionnaire and a semi-directive interview was systematically proposed. We analyzed the ethical issues that arose during the process of decision-making and we made suggestions in order to address them. Results > Sixteen doctors reported twenty-one clinical cases. Of these cases, one third of the children had a change in their oncologic treatment, with a risk of pejorative outcome on the prognosis. Despite the fact that ethical issues appeared in 80 % of the cases, there were few consultations with ethical committees. Decision-making process showed no difference compared to children without intellectual disability, thus raising ethical issues in the medical team. Our study showed discrepancy between frequently reported ethical issues, high consensus rate regarding treatment decision and lack of consultation with ethical committees. Discussion > We propose three steps to guide the decision-making process in situations involving children with intellectual disability and cancer: 1/deeper understanding of the child through reinforced interactions with their caregivers, 2/better cross-boundary discussions, to improve the effectiveness of the multidisciplinary staff, and 3/more systematic ethical committees consultation.
引用
收藏
页码:813 / 826
页数:14
相关论文
共 41 条
  • [21] A bioethical framework to guide the decision-making process in the care of seriously ill patients
    Forte, Daniel Neves
    Kawai, Fernando
    Cohen, Claudio
    [J]. BMC MEDICAL ETHICS, 2018, 19
  • [22] Harrison C, 1997, CAN MED ASSOC J, V156, P825
  • [23] Informed consent instead of assent is appropriate in children from the age of twelve: Policy implications of new findings on children's competence to consent to clinical research
    Hein, Irma M.
    De Vries, Martine C.
    Troost, Pieter W.
    Meynen, Gerben
    Van Goudoever, Johannes B.
    Lindauer, Ramon J. L.
    [J]. BMC Medical Ethics, 2015, 16
  • [24] Imbert G., 2010, RECH SOINS INFIRM, V3, P23, DOI DOI 10.3917/RSI.102.0023
  • [25] INCa, 2014, CANC INFO, P1
  • [27] The Jarde law: What does change
    Lemaire, Francois
    [J]. PRESSE MEDICALE, 2019, 48 (03): : 238 - 242
  • [28] Shared medical decision-making: considering what options to present based on an ethical analysis of the treatment of brain tumors in very young children
    Levine, Deena
    Cohen, Kenneth
    Wendler, David
    [J]. PEDIATRIC BLOOD & CANCER, 2012, 59 (02) : 216 - 220
  • [29] Does ATRX germline variation predispose to osteosarcoma? Three additional cases of osteosarcoma in two ATR-X syndrome patients
    Masliah-Planchon, Julien
    Levy, Dominique
    Heron, Delphine
    Giuliano, Fabienne
    Badens, Catherine
    Freneaux, Paul
    Galmiche, Louise
    Guinebretierre, Jean-Marc
    Cellier, Cecile
    Waterfall, Joshua J.
    Ait-Rais, Khadija
    Pierron, Gaelle
    Glorion, Christophe
    Desguerre, Isabelle
    Soler, Christine
    Deville, Anne
    Delattre, Olivier
    Michon, Jean
    Bourdeaut, Franck
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 (08) : 1217 - 1221
  • [30] Genotype-phenotype correlations in patients with retinoblastoma and interstitial 13q deletions
    Mitter, Diana
    Ullmann, Reinhard
    Muradyan, Artur
    Klein-Hitpass, Ludger
    Kanber, Deniz
    Ounap, Katrin
    Kaulisch, Marc
    Lohmann, Dietmar
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2011, 19 (09) : 947 - 958